86
Participants
Start Date
November 12, 2020
Primary Completion Date
October 17, 2022
Study Completion Date
November 1, 2022
GB002 (seralutinib)
Capsule containing GB002 (seralutinib)
Placebo
Matching capsule containing placebo
Generic Dry Powder Inhaler
Generic dry powder inhaler for GB002 (seralutinib) or placebo delivery
Erasme University Hospital, Brussels
Medizinische Universitat Wien - Universitatsklinik fur Innere Medizin II, Vienna
St Vincent's Hospital, Darlinghurst
University Hospital of Leuven, Leuven
St Vincent's Hospital Melbourne, Fitzroy
LKH - Univ. Klinikum Graz - Universitatsklinik fur Innere Medizin, Graz
NYU Langone Health, New York
New York Presbyterian Hospital - Weill Cornell Medicine, New York
University Clinical Centre of Serbia, Belgrade
DRK Kliniken Berlin - Westend, Berlin
University of Rochester Medical Center, Rochester
Allegheny General Hospital, Pittsburgh
Perelman Center for Advanced Medicine, Philadelphia
Institute for Pulmonary Diseases of Vojvodina, Kamenitz
Hospital Universitario 12 de Octubre, Madrid
The Emory Clinic, Atlanta
Medizinische Hochschule Hannover, Hanover
Mayo Clinic Jacksonville, Jacksonville
Herz- und Diabeteszentrum NRW, Bad Oeynhausen
Central Florida Pulmonary Group, PA, Altamonte Springs
Cleveland Clinic Florida, Weston
CHU de Montpellier - Hopital Arnaud de Villeneuve, Montpellier
Universitätsklinikum Giessen / Marburg, Giessen
Hospital Universitario Marqués de Valdecilla, Santander
Kentuckiana Pulmonary Research Center, Louisville
The Ohio State University Wexner Medical Center, Columbus
Cleveland Clinic Foundation, Cleveland
University of Cincinnati Medical Center, Cincinnati
University of Michigan, Ann Arbor
University of Iowa Hospitals & Clinics, Iowa City
Medical College of Wisconsin - Froedtert Hospital, Milwaukee
University of Minnesota, Minneapolis
Mayo Clinic, Rochester
Washington University School of Medicine, St Louis
University of Kansas Medical Center, Kansas City
University of Nebraska Medical Center, Omaha
Zentrum fur Pulmonale Hypertonie Thoraxklinik-Heidelberg gGmbH, Heidelberg
INTEGRIS Baptist Medical Center, Inc., Oklahoma City
UT Southwestern Medical Center, Dallas
Houston Methodist Hospital, Houston
University of Utah Health, Salt Lake City
Pulmonary Associates, PA, Phoenix
University of New Mexico Health Sciences Center, Albuquerque
Dept of Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles
The Lundquist Institute of Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
Universitatsklinikum Regensburg, Regensburg
Medical Corporation, Santa Barbara
The University of California San Francisco, San Francisco
AP-HP, Hopital de Bicetre, Le Kremlin-Bicêtre
Stanford Healthcare, Stanford
UC Davis Medical Center, Sacramento
Oregon Health & Science University, Portland
Tufts Medical Center, Boston
Brigham and Women's Hospital, Boston
Royal Hobart Hospital, Hobart
Westmead Hospital, Westmead
Sir Mortimer B Davis Jewish General Hospital, Montreal
Peter Lougheed Centre, Calgary
London Health Sciences Centre - Victoria Hospital, London
Všeobecná fakultní nemocnice v Praze, Prague
Hospital Universitario Vall d'Hebron, Barcelona
Royal Papworth Hospital NHS Foundation, Cambridge
Imperial College Healthcare NHS Trust - Hammersmith Medicines Research Limited, London
GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
INDUSTRY